Tiotropium Export Market Intelligence: India's 99 Suppliers Shipping to 50 Countries — TransData Nexus 2026

Q: Who are the top tiotropium exporters from India?

The top tiotropium exporters from India are: 1. LUPIN LIMITED — $54.8M (80.6% market share); 2. CIPLA LIMITED — $10.2M (15.0% market share); 3. VAMSI PHARMA PRIVATE LIMITED — $977.6K (1.4% market share); 4. SYNAPSE PHARMATECH — $674.1K (1.0% market share); 5. SAVA HEALTHCARE LIMITED — $131.7K (0.2% market share). Together they account for 98.3% of India's total tiotropium export value.

Q: What is the total export value of tiotropium from India?

The total export value of tiotropium from India is $67.9M USD, recorded across 2,210 shipment transactions from 99 active exporters to 50 destination countries. The average shipment value is $30.7K.

Q: Which countries import tiotropium from India?

India exports tiotropium to 50 countries worldwide. The top importing countries are: UNITED STATES (80.6% share, $54.8M), MOROCCO (6.3% share, $4.3M), URUGUAY (4.4% share, $3.0M), UNITED ARAB EMIRATES (2.4% share, $1.6M), TURKEY (1.9% share, $1.3M). These five markets account for 95.6% of total export value.

Q: What is the HS code for tiotropium exports from India?

The primary HS code for tiotropium exports from India is 30049099. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) for tracking and reporting pharmaceutical trade flows.

Q: What is the average price of tiotropium exports from India?

The average unit price for tiotropium exports from India is $108.43 USD per unit, with prices ranging from $0.04 to $19552.79 depending on formulation, packaging, and order volume. The total market is valued at $67.9M across 2,210 shipments.

Q: Which ports handle tiotropium exports from India?

The primary ports for tiotropium exports from India are DELHI AIR CARGO ACC (INDEL4) (31.9% of shipments), DELHI AIR (19.2% of shipments), SAHAR AIR (14.6% of shipments), SAHAR AIR CARGO ACC (INBOM4) (7.6% of shipments), Delhi Air (5.9% of shipments). These ports have dedicated pharmaceutical cargo infrastructure ensuring cold-chain and regulatory compliance during transit.

Q: Why is India a leading exporter of tiotropium?

India is one of the world's leading exporters of tiotropium due to its large base of 99 WHO-GMP and US FDA approved manufacturers, significantly lower production costs compared to Western markets, well-established API (Active Pharmaceutical Ingredient) supply chains, and strong government support for pharmaceutical exports through the Pharmaceuticals Export Promotion Council (Pharmexcil). India exports tiotropium to 50 countries, demonstrating 26% global market coverage.

Q: What certifications do Indian tiotropium exporters need?

Indian tiotropium exporters typically require WHO-GMP (Good Manufacturing Practice) certification for most regulated markets, US FDA approval for exports to the United States, EU GMP certification for European markets, and country-specific regulatory approvals for markets in Africa, Asia, and Latin America. Additional certifications may include ISO 9001, Schedule M compliance under Indian drug laws, and Free Sale Certificates issued by the Central Drugs Standard Control Organization (CDSCO).

Q: How many buyers import tiotropium from India?

There are 186 registered buyers importing tiotropium from India, spread across 50 countries. The repeat buyer rate is 56.5%, indicating strong long-term trade relationships and consistent product quality.

Q: What is the market share of the top tiotropium supplier from India?

LUPIN LIMITED is the leading tiotropium exporter from India with a market share of 80.6% and total export value of $54.8M across 45 shipments. The top 5 suppliers together control 98.3% of total export value.

Suresh Sormare

Tiotropium

India Pharmaceutical Trade Intelligence

$67.9M99 Suppliers50 CountriesHS 30049099

ExportsIndia → UNITED STATES80.6%India → MOROCCO6.3%

#1 Supplier: LUPIN LIMITED #1 Buyer: LUPIN INC

Tiotropium Export Analysis | Transdata Nexus | TransData Nexus

How India Exports Tiotropium to the World

Between 2022 and 2026, India exported $67.9M worth of tiotropium across 2,210 verified shipments to 50 countries — covering 26% of world markets in the Respiratory & OTC segment. The largest destination is UNITED STATES (80.6%). LUPIN LIMITED leads with a 80.6% share. All figures are drawn from Indian Customs (DGFT) shipping bill records spanning four years of trade activity.

Source: Indian Customs (DGFT)·Published March 2026·Updated March 2026·HS 30049099

Tiotropium export data from India — top exporters, importing countries, pricing and trade statistics compiled by TransData Nexus — Tiotropium export data snapshot — $67.9M · 99 exporters · 50 countriesTransData Nexus · Indian Customs Data

Top Tiotropium Exporters from India

99 active exporters · Ranked by export value

View all 99 →

Top Tiotropium Exporters from India — Ranked by Export Value
#	Supplier Name	Export Value (USD)	Shipments	Countries	Market Share
1	LUPIN LIMITED	$54.8M	45	2	80.6%
2	CIPLA LIMITED

Top Countries Importing Tiotropium from India

50 destination markets · Ranked by import value

All 50 countries →

Top Countries Importing Tiotropium from India — Ranked by Import Value
#	Country	Import Value (USD)	Market Share
1	UNITED STATES	$54.8M	80.6%
2	MOROCCO	$4.3M	6.3%
3	URUGUAY	$3.0M	4.4%
4	UNITED ARAB EMIRATES	$1.6M	2.4%
5	TURKEY	$1.3M	1.9%
6	GUATEMALA	$728.8K	1.1%
7	SRI LANKA	$507.7K	0.7%
8	COLOMBIA	$306.6K	0.5%
9	PARAGUAY	$295.2K	0.4%
10	MAURITIUS	$256.9K	0.4%

UNITED STATES is India's largest tiotropium export destination, absorbing 80.6% of total exports worth $54.8M. The top 5 importing countries — UNITED STATES, MOROCCO, URUGUAY, UNITED ARAB EMIRATES, TURKEY — together account for 95.6% of India's total tiotropium export value. The remaining 45 destination countries collectively receive the other 4.4%, indicating a broadly diversified export footprint across multiple regions.

Regulatory Landscape — Tiotropium

Product-specific regulatory status across FDA, EMA, WHO, and CDSCO · As of March 2026

1FDA & US Market Regulatory Status

In the United States, tiotropium bromide is approved for the maintenance treatment of COPD. The reference listed drug (RLD), Spiriva HandiHaler (NDA 021395), was approved by the FDA on January 30, 2004. Subsequently, generic versions have entered the market. For instance, Lupin Pharmaceuticals received FDA approval for its Abbreviated New Drug Application (ANDA 211287) for Tiotropium Bromide Inhalation Powder, 18 mcg/capsule, on October 30, 2025. This approval underscores the stringent regulatory pathway involving bioequivalence studies and adherence to Current Good Manufacturing Practices (cGMP). The presence of 99 active Indian exporters highlights the competitive landscape and the importance of maintaining compliance with FDA regulations to ensure market access.

2EU & UK Regulatory Framework

In the European Union, tiotropium bromide is authorized for COPD treatment. The European Medicines Agency (EMA) granted marketing authorization for Spiriva HandiHaler, with the marketing authorization issued on September 30, 2002. The UK, post-Brexit, continues to recognize EMA approvals; however, the Medicines and Healthcare products Regulatory Agency (MHRA) now oversees national authorizations. Manufacturers exporting to these markets must comply with EU Good Manufacturing Practice (GMP) guidelines, ensuring product quality and safety.

3WHO Essential Medicines & Global Standards

Tiotropium bromide is included in the 21st edition of the WHO Model List of Essential Medicines, reflecting its critical role in managing COPD. While not listed under the WHO Prequalification Programme, tiotropium must meet international pharmacopoeial standards, including those of the United States Pharmacopeia (USP), British Pharmacopoeia (BP), European Pharmacopoeia (EP), and Indian Pharmacopoeia (IP), to ensure global quality compliance.

4India Regulatory Classification

In India, tiotropium bromide is classified under Schedule H of the Drugs and Cosmetics Act, indicating it is a prescription-only medication. The National Pharmaceutical Pricing Authority (NPPA) has not set a ceiling price for tiotropium, allowing market-driven pricing. For exports, the Directorate General of Foreign Trade (DGFT) mandates a No Objection Certificate (NOC) to ensure compliance with national regulations and international standards.

5Patent & Exclusivity Status

The primary patents for Spiriva HandiHaler have expired, facilitating the entry of generic versions into the market. This has intensified competition among manufacturers, including Indian exporters, necessitating adherence to regulatory standards to maintain market share.

6Recent Industry Developments

In October 2025, the FDA approved Lupin Pharmaceuticals' ANDA for Tiotropium Bromide Inhalation Powder, marking a significant milestone for Indian manufacturers in the US market. In November 2025, the EMA updated the product information for Ultibro Breezhaler, a combination therapy including indacaterol and glycopyrronium, indicating ongoing regulatory activities in the COPD treatment landscape. (ema.europa.eu) In December 2025, the WHO released the 22nd edition of the Model List of Essential Medicines, reaffirming the inclusion of tiotropium bromide, underscoring its global therapeutic importance.

These developments highlight the dynamic regulatory environment and the necessity for Indian exporters to stay abreast of international standards and approvals to sustain and expand their market presence.

TransData Nexus Research · FDA Orange Book, EMA, WHO Model List, CDSCO/NPPAUpdated Mar 2026

Get Complete Export Intelligence Report

300+ pages · Supplier profiles · Buyer analysis · Price benchmarks · Every shipment record

Free

Global Price Benchmark — Tiotropium

Retail & reference prices across 9 markets vs. India FOB export price of $108.43/unit

Global Price Benchmark for Tiotropium across major pharmaceutical markets
Market	Price (USD/unit)	Currency	Reference
United States	$13.26	USD	According to a 2018 report by the U.S. House of Representatives Ways and Means Committee, the list price for Spiriva Respimat in the U.S. was $13.26 per inhalation.
United Kingdom	$1.58	GBP	The same 2018 report indicates that the list price for Spiriva Respimat in the UK was $1.58 per inhalation.
Germany	$50.13	EUR	The 2018 report lists the price for Spiriva Respimat in Germany as $50.13 per inhalation.
Australia	$2.19

Supply Chain Risk Assessment — Tiotropium

API sourcing, concentration risk, storage requirements, and current alerts

HIGH RISK

1API Sourcing & Raw Material Dependency

Tiotropium bromide, the active pharmaceutical ingredient (API) in Tiotropium formulations, is predominantly manufactured in India. However, the production of this API is heavily reliant on Key Starting Materials (KSMs) sourced from China. China controls approximately 70–80% of the global KSM supply and 60–70% of the global intermediate supply, making it a critical supplier for the pharmaceutical industry. This dependency poses significant risks, as any disruption in the supply of these materials can halt API production, leading to shortages of the final pharmaceutical product.

Recent geopolitical tensions have exacerbated these risks. In March 2026, military conflicts in the Middle East led to the closure of the Strait of Hormuz, a vital maritime chokepoint. This disruption has caused significant delays and increased costs in the transportation of goods, including pharmaceutical raw materials. Such events highlight the vulnerability of supply chains that are heavily dependent on specific regions for critical raw materials.

2Supplier Concentration & Single-Source Risk

The export data for Tiotropium from India reveals a high supplier concentration, with the top five exporters accounting for 98.3% of the total export value. LUPIN LIMITED alone holds an 80.6% share, amounting to $54.8 million USD. This level of concentration indicates a significant single-source risk, as any operational or regulatory issues affecting these key suppliers could disrupt the entire supply chain.

Access Complete Tiotropium Trade Intelligence

Shipment-level records, verified supplier contacts, buyer histories, and pricing analytics for all 2,210 transactions across 50 markets.

Request Demo View Pricing

Frequently Asked Questions — Tiotropium Exports from India

Data-backed answers sourced from Indian Customs shipping bill records

Who are the top tiotropium exporters from India?

The leading tiotropium exporters from India are LUPIN LIMITED, CIPLA LIMITED, VAMSI PHARMA PRIVATE LIMITED, and 8 others. LUPIN LIMITED leads with 80.6% market share ($54.8M). The top 5 suppliers together control 98.3% of total export value.

What is the total export value of tiotropium from India?

The total export value of tiotropium from India is $67.9M, recorded across 2,210 shipments from 99 active exporters to 50 countries. The average shipment value is $30.7K.

Which countries import tiotropium from India?

India exports tiotropium to 50 countries. The top importing countries are UNITED STATES (80.6%), MOROCCO (6.3%), URUGUAY (4.4%), UNITED ARAB EMIRATES (2.4%), TURKEY (1.9%), which together account for 95.6% of total export value.

What is the HS code for tiotropium exports from India?

The primary HS code for tiotropium exports from India is 30049099. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) to track and report pharmaceutical export flows.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Tiotropium

Tiotropium

How India Exports Tiotropium to the World

Top Tiotropium Exporters from India

Top Countries Importing Tiotropium from India

Quick Facts

Related Respiratory & OTC

Related Analysis

Need Details?

Regulatory Landscape — Tiotropium

1FDA & US Market Regulatory Status

2EU & UK Regulatory Framework

3WHO Essential Medicines & Global Standards

4India Regulatory Classification

5Patent & Exclusivity Status

6Recent Industry Developments

Global Price Benchmark — Tiotropium

Supply Chain Risk Assessment — Tiotropium

1API Sourcing & Raw Material Dependency

2Supplier Concentration & Single-Source Risk

Access Complete Tiotropium Trade Intelligence

Frequently Asked Questions — Tiotropium Exports from India

Who are the top tiotropium exporters from India?

What is the total export value of tiotropium from India?

Which countries import tiotropium from India?

What is the HS code for tiotropium exports from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

India Cost Advantage

3Geopolitical & Shipping Disruptions

4Risk Mitigation Recommendations

What is the average price of tiotropium exports from India?

Which ports handle tiotropium exports from India?

Why is India a leading exporter of tiotropium?

What certifications do Indian tiotropium exporters need?

How many buyers import tiotropium from India?

What is the market share of the top tiotropium exporter from India?

Analysis Methodology